Targeting the Apoptosis Pathway in Hematologic Malignancies

Yazar: Zaman, Shadia, Wang, Rui, Gandhi, Varsha
Baskı/Yayın Bilgisi 2014

Targeting executioner procaspase-3 with the procaspase activating compound B-PAC-1 induces apoptosis in multiple myeloma cells

Yazar: Zaman, Shadia, Wang, Rui, Gandhi, Varsha
Yayımlandı Exp Hematol (2015)

Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions

Yazar: Zaman, Shadia, Sarntivijai, Sirarat, Abernethy, Darrell R
Yayımlandı Gene Regul Syst Bio (2017)

Protein Kinase A and Sch9 Cooperatively Regulate Induction of Autophagy in Saccharomyces cerevisiae

Yazar: Yorimitsu, Tomohiro, Zaman, Shadia, Broach, James R., Klionsky, Daniel J.
Baskı/Yayın Bilgisi 2007

Glucose regulates transcription in yeast through a network of signaling pathways

Yazar: Zaman, Shadia, Lippman, Soyeon I, Schneper, Lisa, Slonim, Noam, Broach, James R
Baskı/Yayın Bilgisi 2009

Glucose regulates transcription in yeast through a network of signaling pathways

Yazar: Zaman, Shadia, Lippman, Soyeon I, Schneper, Lisa, Slonim, Noam, Broach, James R
Baskı/Yayın Bilgisi 2009

FBP1 Is an Interacting Partner of Menin

Yazar: Zaman, Shadia, Sukhodolets, Karen, Wang, Patricia, Qin, Jun, Levens, David, Agarwal, Sunita K., Marx, Stephen J.
Baskı/Yayın Bilgisi 2014

Targeting the Pro-Survival Protein MET with Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()

Yazar: Zaman, Shadia, Shentu, Shujun, Yang, Jing, He, Jin, Orlowski, Robert Z., Stellrecht, Christine M., Gandhi, Varsha
Yayımlandı Neoplasia (2015)

The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization

Yazar: Wang, Yan, Ozawa, Atsushi, Zaman, Shadia, Prasad, Nijaguna B., Chandrasekharappa, Settara C., Agarwal, Sunita K., Marx, Stephen J.
Baskı/Yayın Bilgisi 2010

Linking MedDRA®-coded Clinical Phenotypes to Biological Mechanisms by The Ontology of Adverse Events: A pilot study on Tyrosine Kinase Inhibitors (TKIs)

Yazar: Sarntivijai, Sirarat, Zhang, Shelley, Jagannathan, Desikan G., Zaman, Shadia, Burkhart, Keith K., Omenn, Gilbert S., He, Yongqun, Athey, Brian D., Abernethy, Darrell R.
Yayımlandı Drug Saf (2016)

Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines

Yazar: Phillip, Cornel Joseph, Zaman, Shadia, Shentu, Shujun, Balakrishnan, Kumudha, Zhang, Jiexin, Baladandayuthapani, Veera, Taverna, Pietro, Redkar, Sanjeev, Wang, Michael, Stellrecht, Christine Marie, Gandhi, Varsha
Baskı/Yayın Bilgisi 2013

Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines

Yazar: Phillip, Cornel Joseph, Zaman, Shadia, Shentu, Shujun, Balakrishnan, Kumudha, Zhang, Jiexin, Baladandayuthapani, Veera, Taverna, Pietro, Redkar, Sanjeev, Wang, Michael, Stellrecht, Christine Marie, Gandhi, Varsha
Yayımlandı J Hematol Oncol (2016)

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma

Yazar: Baljevic, Muhamed, Zaman, Shadia, Baladandayuthapani, Veerabhadran, Lin, Yan Heather, de Partovi, Claudia Morales, Berkova, Zuzana, Amini, Behrang, Thomas, Sheeba K., Shah, Jatin J., Weber, Donna M., Fu, Min, Cleeland, Charles S., Wang, Xin Shelley, Stellrecht, Christine M., Davis, Richard E., Gandhi, Varsha, Orlowski, Robert Z.
Yayımlandı Ann Hematol (2017)